The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126030001 12603000 1 I 20160629 20160721 20160728 20160728 EXP FR-PFIZER INC-2016355888 PFIZER 56.00 YR M Y 0.00000 20160728 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126030001 12603000 1 PS Zyvoxid LINEZOLID 1 Oral 600 MG, 2X/DAY 4800 MG Y 21130 600 MG FILM-COATED TABLET BID
126030001 12603000 2 SS ROCEPHINE CEFTRIAXONE SODIUM 1 Intravenous (not otherwise specified) 2 G, DAILY Y 0 2 G
126030001 12603000 3 SS FLAGYL METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE 1 Oral 500 MG, 3X/DAY 10500 MG Y 0 500 MG FILM-COATED TABLET TID
126030001 12603000 4 SS ROVAMYCINE /00074401/ SPIRAMYCIN 1 Intravenous drip 2 DF, 3X/DAY 42 DF Y 0 2 DF TID
126030001 12603000 5 SS WELLVONE ATOVAQUONE 1 Oral 1 DF, 2X/DAY 14 DF Y 0 1 DF BID
126030001 12603000 6 SS COLCHICINE. COLCHICINE 1 Oral 0.5 MG, DAILY Y 0 .5 MG
126030001 12603000 7 C MYFORTIC MYCOPHENOLATE SODIUM 1 180 MG, 2X/DAY 0 180 MG BID
126030001 12603000 8 C NEORAL CYCLOSPORINE 1 70 MG, 2X/DAY 0 70 MG BID
126030001 12603000 9 C ICAZ ISRADIPINE 1 5 MG, 3X/DAY 0 5 MG TID
126030001 12603000 10 C LASILIX /00032601/ FUROSEMIDE 1 20 MG, DAILY 0 20 MG
126030001 12603000 11 C NEBIVOLOL. NEBIVOLOL 1 5 MG, 1X/DAY 0 5 MG QD
126030001 12603000 12 C ARANESP DARBEPOETIN ALFA 1 UNK, MONTHLY 0 /month
126030001 12603000 13 C TARDYFERON FERROUS SULFATE 1 1 DF, 1X/DAY 0 1 DF QD
126030001 12603000 14 C UVEDOSE CHOLECALCIFEROL 1 1 DF, MONTHLY 0 1 DF /month
126030001 12603000 15 C ZYLORIC ALLOPURINOL 1 300 MG, 1X/DAY 0 300 MG QD
126030001 12603000 16 C PENTACARINAT PENTAMIDINE ISETHIONATE 1 Respiratory (inhalation) 300 MG, MONTHLY 0 300 MG /month

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126030001 12603000 1 Staphylococcal infection
126030001 12603000 2 Pneumonia
126030001 12603000 3 Pneumonia
126030001 12603000 4 Pneumonia
126030001 12603000 5 Prophylaxis
126030001 12603000 6 Gout

Outcome of event

Event ID CASEID OUTC COD
126030001 12603000 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126030001 12603000 Mouth ulceration
126030001 12603000 Rash
126030001 12603000 Tongue ulceration

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126030001 12603000 1 20160626 20160630 0
126030001 12603000 2 20160623 20160701 0
126030001 12603000 3 20160623 20160630 0
126030001 12603000 4 20160623 20160630 0
126030001 12603000 5 20160623 20160704 0
126030001 12603000 6 20160628 20160630 0